Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Promotes Migration of Human Bone Marrow Multipotent Stromal Cells

被引:55
作者
Secchiero, Paola
Melloni, Elisabetta
Corallini, Federica
Beltrami, Antonio Paolo [2 ]
Alviano, Francesco [3 ]
Milani, Daniela
D'Aurizio, Federica [2 ]
Di Iasio, Maria Grazia
Cesselli, Daniela [2 ]
Bagnara, Gian Paolo [3 ]
Zauli, Giorgio [1 ]
机构
[1] Univ Ferrara, Dept Morphol & Embryol, Human Anat Sect, I-44100 Ferrara, Italy
[2] Univ Udine, Interdepartmental Ctr Regenerat Med, I-33100 Udine, Italy
[3] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy
关键词
Tumor necrosis factor-related apoptosis-inducing ligand; Tumor necrosis factor-related apoptosis-inducing ligand receptors; Multipotent precursor; Mesenchymal stem cells; Migration;
D O I
10.1634/stemcells.2008-0512
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Adult multipotent stromal cells (MSCs), also known as mesenchymal stem cells, represent an important source of cells for the repair of a number of damaged tissues. Both bone marrow (BM)-derived and amniotic MSCs expressed detectable surface levels of two (tumor necrosis factor-related apoptosis-inducing ligand receptor 2 [TRAIL-R2] and TRAIL-R4) of four transmembrane TRAIL receptors. Although the best-characterized activity of TRAIL-R2 is the transduction of apoptotic signals, neither recombinant TRAIL (rTRAIL) nor infection with an adenovirus-expressing TRAIL induced cytotoxic effects on MSCs. Moreover, whereas rTRAIL did not affect proliferation or differentiation of MSCs along the osteogenic and adipogenic lineages, it significantly promoted the migration of human MSCs in range of concentrations comparable to that of soluble TRAIL in human plasma (100 pg/ml). Since rTRAIL induced the rapid phosphorylation of extracellular signal-regulated kinase 1/2 ( ERK1/2) in MSC cultures and pretreatment with pharmacological inhibitors of the ERK1/2 pathway efficiently counteracted the rTRAIL-induced human MSC migration, these data indicate that ERK1/2 is involved in mediating the ability of rTRAIL to stimulate MSC migration. Taking into consideration that the soluble factors able to induce MSC migration have not been extensively characterized, our current data indicate that the TRAIL/TRAIL-R system might play an important role in the biology of MSCs. STEM CELLS 2008;26:2955-2963
引用
收藏
页码:2955 / 2963
页数:9
相关论文
共 40 条
[1]   Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro [J].
Alviano, Francesco ;
Fossati, Valentina ;
Marchionni, Cosetta ;
Arpinati, Mario ;
Bonsi, Laura ;
Franchina, Michele ;
Lanzoni, Giacomo ;
Cantoni, Silvia ;
Cavallini, Claudia ;
Bianchi, Francesca ;
Tazzari, Pier Luigi ;
Pasquinelli, Gianandrea ;
Foroni, Laura ;
Ventura, Carlo ;
Grossi, Alberto ;
Bagnara, Gian Paolo .
BMC DEVELOPMENTAL BIOLOGY, 2007, 7
[2]   Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow) [J].
Beltrami, Antonio R. ;
Cesselli, Daniela ;
Bergamin, Natascha ;
Marcon, Patrizia ;
Rigo, Silvia ;
Puppato, Elisa ;
D'Aurizio, Federica ;
Verardo, Roberto ;
Piazza, Silvano ;
Pignatelli, Angela ;
Poz, Alessandra ;
Baccarani, Umberto ;
Damiani, Daniela ;
Fanin, Renato ;
Mariuzzi, Laura ;
Finato, Nicoletta. ;
Masolini, Paola ;
Burelli, Silvia ;
Belfuzzi, Ottorino ;
Schneider, Claudio ;
Beltrami, Carlo A. .
BLOOD, 2007, 110 (09) :3438-3446
[3]   Expression and function of TNF-family proteins and receptors in human osteoblasts [J].
Bu, RF ;
Borysenko, CW ;
Li, YN ;
Cao, LH ;
Sabokbar, A ;
Blair, HC .
BONE, 2003, 33 (05) :760-770
[4]   Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes [J].
Campioni, D ;
Secchiero, P ;
Corallini, F ;
Melloni, E ;
Capitani, S ;
Lanza, F ;
Zauli, G .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (02) :557-563
[5]   Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators [J].
Cassatella, MA ;
Huber, V ;
Calzetti, F ;
Margotto, D ;
Tamassia, N ;
Peri, G ;
Mantovani, A ;
Rivoltini, L ;
Tecchio, C .
JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 79 (01) :123-132
[6]   Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing [J].
Chamberlain, Giselle ;
Fox, James ;
Ashton, Brian ;
Middleton, Jim .
STEM CELLS, 2007, 25 (11) :2739-2749
[7]   Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-β, and Copaxone [J].
Croitoru-Lamoury, Juliana ;
Lamoury, Francois M. J. ;
Zaunders, John J. ;
Veas, Laura A. ;
Brew, Bruce J. .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (01) :53-64
[8]   Recent advances into the understanding of mesenchymal stem cell trafficking [J].
Fox, James M. ;
Chamberlain, Giselle ;
Ashton, Brian A. ;
Middleton, Jim .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (06) :491-502
[9]   RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men [J].
Gibellini, Davide ;
Borderi, Marco ;
De Crignis, Elisa ;
Cicola, Ronny ;
Vescini, Fabio ;
Caudarella, Renata ;
Chiodo, Francesco ;
Re, Maria Carla .
JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (10) :1446-1454
[10]   From the laboratory bench to the patients bedside: An update on clinical trials with mesenchymal stem cells [J].
Giordano, Antonio ;
Galderisi, Umberto ;
Marino, Ignazio R. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 211 (01) :27-35